Cargando…
Cardiovascular Risk Reduction with Renin-Angiotensin Aldosterone System Blockade
This paper examines the evidence supporting treatments within the renin-angiotensin aldosterone system (RAS), the role cardioprotection plays within the management of hypertension, considerations around medication adherence, and the role of the nurse or nurse practitioner in guiding patients to achi...
Autor principal: | Houston Miller, Nancy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169243/ https://www.ncbi.nlm.nih.gov/pubmed/21994809 http://dx.doi.org/10.1155/2010/101749 |
Ejemplares similares
-
Management of proteinuria: blockade of the renin–angiotensin–aldosterone system
por: Athavale, Akshay, et al.
Publicado: (2020) -
Renin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences
por: Lozano-Maneiro, Luz, et al.
Publicado: (2015) -
Dual Blockade of the Renin-angiotensin-aldosterone System in Type 2 Diabetic Kidney Disease
por: Feng, Yan-Huan, et al.
Publicado: (2016) -
Emergence and evolution of the renin–angiotensin–aldosterone system
por: Fournier, David, et al.
Publicado: (2012) -
Role of the Renin-Angiotensin System and Aldosterone on Cardiometabolic Syndrome
por: Stiefel, P., et al.
Publicado: (2011)